Issue Date: November 21, 2011
China’s WuXi Starts Venture Capital Fund
WuXi PharmaTech, a Chinese contract research and manufacturing firm, has formed a $50 million venture capital fund. The Shanghai-based contractor hopes to profit both from the capital appreciation of the companies it invests in and by accessing technology they develop. “This fund will invest in technologies and life sciences companies to enhance our platform capabilities and to help great minds realize the potential of their technologies and intellectual property,” says WuXi CEO Ge Li.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society